Comparative Pharmacology
Head-to-head clinical analysis: DIALYTE LM DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL LOW CALCIUM W DEXTROSE 4 25 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIALYTE LM DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL LOW CALCIUM W DEXTROSE 4 25 IN PLASTIC CONTAINER.
DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER vs DIANEAL LOW CALCIUM W/DEXTROSE 4.25% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Peritoneal dialysis solution with dextrose as osmotic agent; dextrose creates osmotic gradient across peritoneal membrane to remove excess fluid and uremic toxins.
Sterile, nonpyrogenic, hyperosmotic solution containing dextrose as osmotic agent; creates osmotic gradient across peritoneal membrane to remove excess fluid and waste products via diffusion and ultrafiltration.
Intraperitoneal administration via automated peritoneal dialysis (APD) or continuous ambulatory peritoneal dialysis (CAPD); typical adult dose is 2-3 liters per exchange, 4-5 exchanges per day (CAPD) or 8-12 liters total volume per night (APD).
Intraperitoneal administration: 2 liters per exchange, 4 exchanges daily, with dwell times of 4-6 hours; dextrose concentration adjusted to achieve ultrafiltration goals.
None Documented
None Documented
Not applicable: Dextrose absorbed from peritoneal dialysate has a half-life similar to IV glucose (approx. 1-2 hours), but as a dialysis solution, the concept of terminal elimination half-life is not defined for the non-absorbed components. Clinical context: continuous intraperitoneal administration.
Not applicable for intraperitoneal dextrose; systemic glucose half-life ~1.5-3 h in normal metabolic state. Peritoneal dialysis of dextrose reflects continuous absorption and metabolism.
Peritoneal dialysis fluid: DIALYTE components (electrolytes, dextrose) are not systemically absorbed in clinically significant amounts; dextrose is partially absorbed across the peritoneum and metabolized. Renal and biliary excretion are not relevant as this is a topical intraperitoneal solution. Elimination of absorbed dextrose follows glucose metabolism (oxidation, storage).
Peritoneal elimination; glucose absorbed systemically is metabolized via glycolysis, with <5% excreted unchanged in urine. Dextrose removal relies on diffusion into dialysate; net ultrafiltrate exits via peritoneal catheter.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution